Antibiotice Iasi Net Profit Spikes 114% YoY To RON8.6M In 1Q/2022

05.13.2022 By Ecaterina Craciun

Antibiotice Iasi (ATB.RO), the biggest Romanian-held drug maker, reported a net profit net of RON8.6 million for the first three months of 2022, up 113.7% from the year-earlier period, in line with calculations by Ziarul Financiar (ZF) daily based on the company’s financial report.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 25 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
Antibiotice Iasi
, earnings

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.